

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.60951425 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 3.91472504 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 3.91472504 |
| 4 | nucleobase catabolic process (GO:0046113) | 3.72196327 |
| 5 | negative regulation of cell killing (GO:0031342) | 3.71855597 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.71855597 |
| 7 | activated T cell proliferation (GO:0050798) | 3.65642199 |
| 8 | sensory perception of smell (GO:0007608) | 3.54500379 |
| 9 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.35203100 |
| 10 | tolerance induction (GO:0002507) | 3.28419408 |
| 11 | gamma-aminobutyric acid transport (GO:0015812) | 3.26377285 |
| 12 | negative T cell selection (GO:0043383) | 3.19382381 |
| 13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.19323271 |
| 14 | positive regulation of mitochondrial fission (GO:0090141) | 3.18796379 |
| 15 | detection of calcium ion (GO:0005513) | 3.13149660 |
| 16 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.04638630 |
| 17 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.04117971 |
| 18 | vocalization behavior (GO:0071625) | 3.03009763 |
| 19 | negative thymic T cell selection (GO:0045060) | 3.01406041 |
| 20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.01272847 |
| 21 | activation of protein kinase A activity (GO:0034199) | 2.96390673 |
| 22 | ER overload response (GO:0006983) | 2.93684954 |
| 23 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.92281202 |
| 24 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.92181550 |
| 25 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.92181550 |
| 26 | establishment of mitochondrion localization (GO:0051654) | 2.88434869 |
| 27 | synaptic vesicle maturation (GO:0016188) | 2.88363093 |
| 28 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.87153075 |
| 29 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.87034202 |
| 30 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.87010859 |
| 31 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.84342427 |
| 32 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.82088894 |
| 33 | protein maturation by protein folding (GO:0022417) | 2.81057376 |
| 34 | regulation of neurotransmitter levels (GO:0001505) | 2.80601982 |
| 35 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.78403209 |
| 36 | regulation of beta-amyloid formation (GO:1902003) | 2.78026654 |
| 37 | synaptic transmission, glutamatergic (GO:0035249) | 2.76655835 |
| 38 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.76417334 |
| 39 | cellular potassium ion homeostasis (GO:0030007) | 2.76174625 |
| 40 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.75683108 |
| 41 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.71961743 |
| 42 | glycosphingolipid biosynthetic process (GO:0006688) | 2.71432473 |
| 43 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.71404168 |
| 44 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.69879500 |
| 45 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.69288107 |
| 46 | negative regulation of B cell mediated immunity (GO:0002713) | 2.69288107 |
| 47 | toxin metabolic process (GO:0009404) | 2.68772659 |
| 48 | signal peptide processing (GO:0006465) | 2.68298999 |
| 49 | synaptic vesicle exocytosis (GO:0016079) | 2.68153421 |
| 50 | protein localization to synapse (GO:0035418) | 2.65939953 |
| 51 | neuron-neuron synaptic transmission (GO:0007270) | 2.62317075 |
| 52 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.61511846 |
| 53 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.61321198 |
| 54 | postsynaptic membrane organization (GO:0001941) | 2.61033589 |
| 55 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.60286975 |
| 56 | protein retention in ER lumen (GO:0006621) | 2.58638620 |
| 57 | synapse assembly (GO:0007416) | 2.57535712 |
| 58 | cellular response to glucagon stimulus (GO:0071377) | 2.55431252 |
| 59 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.55138626 |
| 60 | neuromuscular process controlling posture (GO:0050884) | 2.54737184 |
| 61 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.53962876 |
| 62 | axonemal dynein complex assembly (GO:0070286) | 2.53001864 |
| 63 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.50873051 |
| 64 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.50207429 |
| 65 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.50207429 |
| 66 | potassium ion homeostasis (GO:0055075) | 2.48395595 |
| 67 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.47892343 |
| 68 | presynaptic membrane assembly (GO:0097105) | 2.47585975 |
| 69 | long-term synaptic potentiation (GO:0060291) | 2.46910002 |
| 70 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.46363633 |
| 71 | glutamate receptor signaling pathway (GO:0007215) | 2.45750576 |
| 72 | sodium ion export (GO:0071436) | 2.45145746 |
| 73 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.44982159 |
| 74 | regulation of synaptic vesicle transport (GO:1902803) | 2.44332945 |
| 75 | axoneme assembly (GO:0035082) | 2.42301574 |
| 76 | auditory behavior (GO:0031223) | 2.41401330 |
| 77 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.40802172 |
| 78 | cilium movement (GO:0003341) | 2.40571293 |
| 79 | neuronal ion channel clustering (GO:0045161) | 2.39808149 |
| 80 | presynaptic membrane organization (GO:0097090) | 2.39416786 |
| 81 | sensory perception of chemical stimulus (GO:0007606) | 2.39040374 |
| 82 | neuron cell-cell adhesion (GO:0007158) | 2.38861303 |
| 83 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.38773615 |
| 84 | organelle transport along microtubule (GO:0072384) | 2.38475682 |
| 85 | sialylation (GO:0097503) | 2.37850445 |
| 86 | synaptic vesicle transport (GO:0048489) | 2.37796696 |
| 87 | establishment of synaptic vesicle localization (GO:0097480) | 2.37796696 |
| 88 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.37064089 |
| 89 | creatine metabolic process (GO:0006600) | 2.36663737 |
| 90 | glutamate secretion (GO:0014047) | 2.35762948 |
| 91 | potassium ion import (GO:0010107) | 2.35617700 |
| 92 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.34512039 |
| 93 | peptide hormone processing (GO:0016486) | 2.34047473 |
| 94 | mating behavior (GO:0007617) | 2.33692644 |
| 95 | establishment of vesicle localization (GO:0051650) | 2.33593121 |
| 96 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.32898967 |
| 97 | positive T cell selection (GO:0043368) | 2.31949278 |
| 98 | regulation of feeding behavior (GO:0060259) | 2.30911533 |
| 99 | response to auditory stimulus (GO:0010996) | 2.30610894 |
| 100 | positive regulation of membrane potential (GO:0045838) | 2.30339151 |
| 101 | neurofilament cytoskeleton organization (GO:0060052) | 2.30250414 |
| 102 | epithelial cilium movement (GO:0003351) | 2.29848936 |
| 103 | response to dietary excess (GO:0002021) | 2.29073917 |
| 104 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.28742260 |
| 105 | acidic amino acid transport (GO:0015800) | 2.28523467 |
| 106 | cellular response to interleukin-15 (GO:0071350) | 2.28150394 |
| 107 | nucleoside diphosphate catabolic process (GO:0009134) | 2.27807746 |
| 108 | protein insertion into membrane (GO:0051205) | 2.27001627 |
| 109 | dopamine biosynthetic process (GO:0042416) | 2.26374433 |
| 110 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.26195049 |
| 111 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.26028928 |
| 112 | exploration behavior (GO:0035640) | 2.26026495 |
| 113 | dendritic spine morphogenesis (GO:0060997) | 2.25947439 |
| 114 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.25508465 |
| 115 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.24753772 |
| 116 | positive regulation of granulocyte differentiation (GO:0030854) | 2.24527200 |
| 117 | dendritic spine organization (GO:0097061) | 2.24455075 |
| 118 | central nervous system myelination (GO:0022010) | 2.24335351 |
| 119 | axon ensheathment in central nervous system (GO:0032291) | 2.24335351 |
| 120 | regulation of autophagic vacuole assembly (GO:2000785) | 2.24108300 |
| 121 | relaxation of cardiac muscle (GO:0055119) | 2.23623548 |
| 122 | neurotransmitter biosynthetic process (GO:0042136) | 2.23483326 |
| 123 | regulation of neurotransmitter secretion (GO:0046928) | 2.22486540 |
| 124 | regulation of gamma-delta T cell activation (GO:0046643) | 2.21637248 |
| 125 | T cell migration (GO:0072678) | 2.21392593 |
| 126 | succinate metabolic process (GO:0006105) | 2.21239357 |
| 127 | response to pheromone (GO:0019236) | 2.21219310 |
| 128 | response to interleukin-15 (GO:0070672) | 2.20921595 |
| 129 | cell communication by electrical coupling (GO:0010644) | 2.18760132 |
| 130 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.18208116 |
| 131 | regulation of interleukin-4 production (GO:0032673) | 2.17618150 |
| 132 | neuronal action potential propagation (GO:0019227) | 2.17145208 |
| 133 | regulation of synapse structural plasticity (GO:0051823) | 2.16546860 |
| 134 | cerebellar Purkinje cell layer development (GO:0021680) | 2.15545764 |
| 135 | vesicle coating (GO:0006901) | 2.13982620 |
| 136 | protein localization to cilium (GO:0061512) | 2.12481640 |
| 137 | negative regulation of inclusion body assembly (GO:0090084) | 2.11476468 |
| 138 | magnesium ion transport (GO:0015693) | 2.10995189 |
| 139 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.09850846 |
| 140 | insulin secretion (GO:0030073) | 2.09727084 |
| 141 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.09499872 |
| 142 | positive regulation of potassium ion transport (GO:0043268) | 2.08179854 |
| 143 | protein targeting to Golgi (GO:0000042) | 2.06228696 |
| 144 | COPII vesicle coating (GO:0048208) | 2.05220632 |
| 145 | neurotransmitter secretion (GO:0007269) | 2.04438180 |
| 146 | positive regulation of insulin secretion (GO:0032024) | 2.03337782 |
| 147 | regulation of insulin secretion (GO:0050796) | 2.00792076 |
| 148 | locomotory exploration behavior (GO:0035641) | 2.00220609 |
| 149 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 1.99566763 |
| 150 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 1.99340816 |
| 151 | regulation of vesicle fusion (GO:0031338) | 1.98997589 |
| 152 | positive regulation of exocytosis (GO:0045921) | 1.96940918 |
| 153 | neurotransmitter transport (GO:0006836) | 1.96127773 |
| 154 | regulation of ARF protein signal transduction (GO:0032012) | 1.95995023 |
| 155 | transmission of nerve impulse (GO:0019226) | 1.94915639 |
| 156 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 1.94824238 |
| 157 | protein localization to Golgi apparatus (GO:0034067) | 1.93736444 |
| 158 | vesicle transport along microtubule (GO:0047496) | 1.93231045 |
| 159 | negative regulation of neurotransmitter transport (GO:0051589) | 1.93142128 |
| 160 | cellular copper ion homeostasis (GO:0006878) | 1.93118428 |
| 161 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 1.93069401 |
| 162 | nerve growth factor signaling pathway (GO:0038180) | 1.92237259 |
| 163 | macroautophagy (GO:0016236) | 1.91548683 |
| 164 | positive regulation of growth hormone secretion (GO:0060124) | 1.91022353 |
| 165 | negative regulation of glycoprotein metabolic process (GO:1903019) | 1.90997233 |
| 166 | response to glucagon (GO:0033762) | 1.90900498 |
| 167 | regulation of neuronal synaptic plasticity (GO:0048168) | 1.89749384 |
| 168 | membrane repolarization (GO:0086009) | 1.87785212 |
| 169 | regulation of isotype switching to IgG isotypes (GO:0048302) | 1.87269263 |
| 170 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 1.86942002 |
| 171 | positive regulation of nuclease activity (GO:0032075) | 1.86383743 |
| 172 | positive regulation of peptide secretion (GO:0002793) | 1.86059324 |
| 173 | endocrine pancreas development (GO:0031018) | 1.85954058 |
| 174 | layer formation in cerebral cortex (GO:0021819) | 1.85950176 |
| 175 | photoreceptor cell differentiation (GO:0046530) | 1.85876978 |
| 176 | eye photoreceptor cell differentiation (GO:0001754) | 1.85876978 |
| 177 | L-serine transport (GO:0015825) | 1.85461755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.28436662 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.65678738 |
| 3 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.18099434 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.12801866 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.12020030 |
| 6 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.06389939 |
| 7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.97189668 |
| 8 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.96522664 |
| 9 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.91923407 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.86192760 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.84343981 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.81827839 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.80027721 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.79495597 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.76737352 |
| 16 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.76303002 |
| 17 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.75635753 |
| 18 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.69926639 |
| 19 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.69926639 |
| 20 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.64073337 |
| 21 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.62755167 |
| 22 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.61756014 |
| 23 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.58515816 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.50477689 |
| 25 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.48449690 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.43723071 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41060032 |
| 28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.39034130 |
| 29 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.38714517 |
| 30 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.37206686 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.29048997 |
| 32 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.28534911 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.28019260 |
| 34 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.27250180 |
| 35 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.26639665 |
| 36 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.25601911 |
| 37 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.25394144 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.23989422 |
| 39 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.21826300 |
| 40 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.17591256 |
| 41 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.16021075 |
| 42 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.12067984 |
| 43 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.11575280 |
| 44 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.10872195 |
| 45 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10382910 |
| 46 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.10282722 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09124874 |
| 48 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.08349956 |
| 49 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08188045 |
| 50 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.07186339 |
| 51 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.06992599 |
| 52 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.05712069 |
| 53 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05100956 |
| 54 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.04973238 |
| 55 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.04915035 |
| 56 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.03357713 |
| 57 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02734425 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02463609 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01618751 |
| 60 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01548044 |
| 61 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01269892 |
| 62 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.00143861 |
| 63 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99755162 |
| 64 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.99307940 |
| 65 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99291899 |
| 66 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.98272182 |
| 67 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.97014484 |
| 68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96678665 |
| 69 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.96411317 |
| 70 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.96091175 |
| 71 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95562364 |
| 72 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.95546639 |
| 73 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.95515302 |
| 74 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94576405 |
| 75 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.94070198 |
| 76 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.92830480 |
| 77 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.92528056 |
| 78 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.92308705 |
| 79 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.91804615 |
| 80 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.91032649 |
| 81 | MYB_26560356_Chip-Seq_TH2_Human | 0.90928790 |
| 82 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90323729 |
| 83 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.90238433 |
| 84 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.90200816 |
| 85 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.90092362 |
| 86 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.89583692 |
| 87 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89539056 |
| 88 | STAT3_23295773_ChIP-Seq_U87_Human | 0.89432039 |
| 89 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.89250707 |
| 90 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.89221007 |
| 91 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.88409027 |
| 92 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88068840 |
| 93 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.87965353 |
| 94 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.87559705 |
| 95 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87339044 |
| 96 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.87197141 |
| 97 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.86946992 |
| 98 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.86371758 |
| 99 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.85502074 |
| 100 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.85502074 |
| 101 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.84522107 |
| 102 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.83955172 |
| 103 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83607214 |
| 104 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.83576551 |
| 105 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.82992270 |
| 106 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.82601272 |
| 107 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.82535076 |
| 108 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.82422941 |
| 109 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.82252824 |
| 110 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.82127198 |
| 111 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.81892221 |
| 112 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.81694610 |
| 113 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.81675240 |
| 114 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.81521222 |
| 115 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.81177916 |
| 116 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.80684046 |
| 117 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.80077656 |
| 118 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.80054467 |
| 119 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.80004316 |
| 120 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.79790622 |
| 121 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.79402252 |
| 122 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79267620 |
| 123 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.79221733 |
| 124 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.79019100 |
| 125 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.78976641 |
| 126 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.78671016 |
| 127 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.77964000 |
| 128 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.77799770 |
| 129 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.77721662 |
| 130 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.77559260 |
| 131 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.76490650 |
| 132 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76355805 |
| 133 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76355805 |
| 134 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76253871 |
| 135 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.75967319 |
| 136 | AR_25329375_ChIP-Seq_VCAP_Human | 0.75753734 |
| 137 | P300_19829295_ChIP-Seq_ESCs_Human | 0.75720188 |
| 138 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.75429241 |
| 139 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.75181369 |
| 140 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.75060196 |
| 141 | KDM2B_26808549_Chip-Seq_K562_Human | 0.74957850 |
| 142 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.74700287 |
| 143 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.73776673 |
| 144 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.72309494 |
| 145 | VDR_22108803_ChIP-Seq_LS180_Human | 0.72065258 |
| 146 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.70743493 |
| 147 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.69771926 |
| 148 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69760669 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001984_abnormal_olfaction | 3.44134500 |
| 2 | MP0002909_abnormal_adrenal_gland | 3.00531701 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 2.83514863 |
| 4 | MP0003329_amyloid_beta_deposits | 2.78931939 |
| 5 | MP0000013_abnormal_adipose_tissue | 2.40968786 |
| 6 | MP0005645_abnormal_hypothalamus_physiol | 2.40512281 |
| 7 | MP0003787_abnormal_imprinting | 2.38137283 |
| 8 | MP0003724_increased_susceptibility_to | 2.31855228 |
| 9 | MP0004270_analgesia | 2.31015423 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 2.24916295 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 2.23809040 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.07062971 |
| 13 | MP0003880_abnormal_central_pattern | 2.05672100 |
| 14 | MP0004043_abnormal_pH_regulation | 2.03211766 |
| 15 | MP0001501_abnormal_sleep_pattern | 1.94425155 |
| 16 | MP0009780_abnormal_chondrocyte_physiolo | 1.91324946 |
| 17 | MP0002064_seizures | 1.86363035 |
| 18 | MP0002272_abnormal_nervous_system | 1.85652999 |
| 19 | MP0003195_calcinosis | 1.83018784 |
| 20 | MP0002822_catalepsy | 1.82141143 |
| 21 | MP0002693_abnormal_pancreas_physiology | 1.73932573 |
| 22 | MP0000465_gastrointestinal_hemorrhage | 1.70648096 |
| 23 | MP0006276_abnormal_autonomic_nervous | 1.70240501 |
| 24 | MP0001502_abnormal_circadian_rhythm | 1.67817289 |
| 25 | MP0002653_abnormal_ependyma_morphology | 1.67199152 |
| 26 | MP0009745_abnormal_behavioral_response | 1.67080782 |
| 27 | MP0005671_abnormal_response_to | 1.66117631 |
| 28 | MP0004858_abnormal_nervous_system | 1.65817024 |
| 29 | MP0000604_amyloidosis | 1.65149776 |
| 30 | MP0003183_abnormal_peptide_metabolism | 1.64834654 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.64748425 |
| 32 | MP0010386_abnormal_urinary_bladder | 1.64715333 |
| 33 | MP0005379_endocrine/exocrine_gland_phen | 1.60665830 |
| 34 | MP0002063_abnormal_learning/memory/cond | 1.59102904 |
| 35 | MP0001944_abnormal_pancreas_morphology | 1.58137331 |
| 36 | MP0005535_abnormal_body_temperature | 1.57942153 |
| 37 | MP0005423_abnormal_somatic_nervous | 1.55636426 |
| 38 | MP0002734_abnormal_mechanical_nocicepti | 1.53927506 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.50894611 |
| 40 | MP0002572_abnormal_emotion/affect_behav | 1.49010586 |
| 41 | MP0002102_abnormal_ear_morphology | 1.47961036 |
| 42 | MP0002735_abnormal_chemical_nociception | 1.46732716 |
| 43 | MP0002733_abnormal_thermal_nociception | 1.46167567 |
| 44 | MP0004510_myositis | 1.45872375 |
| 45 | MP0000920_abnormal_myelination | 1.45717817 |
| 46 | MP0003763_abnormal_thymus_physiology | 1.39162041 |
| 47 | MP0000778_abnormal_nervous_system | 1.38642289 |
| 48 | MP0001486_abnormal_startle_reflex | 1.35857036 |
| 49 | MP0001970_abnormal_pain_threshold | 1.35294275 |
| 50 | MP0001188_hyperpigmentation | 1.33427029 |
| 51 | MP0001905_abnormal_dopamine_level | 1.33317332 |
| 52 | MP0002877_abnormal_melanocyte_morpholog | 1.30799304 |
| 53 | MP0004130_abnormal_muscle_cell | 1.30240648 |
| 54 | MP0003633_abnormal_nervous_system | 1.29843178 |
| 55 | MP0002078_abnormal_glucose_homeostasis | 1.29234667 |
| 56 | MP0004811_abnormal_neuron_physiology | 1.28348725 |
| 57 | MP0003634_abnormal_glial_cell | 1.28211721 |
| 58 | MP0002736_abnormal_nociception_after | 1.27812219 |
| 59 | MP0001765_abnormal_ion_homeostasis | 1.26250670 |
| 60 | MP0008961_abnormal_basal_metabolism | 1.26005133 |
| 61 | MP0003690_abnormal_glial_cell | 1.25139528 |
| 62 | MP0003436_decreased_susceptibility_to | 1.24049129 |
| 63 | MP0008569_lethality_at_weaning | 1.20460209 |
| 64 | MP0002557_abnormal_social/conspecific_i | 1.19402399 |
| 65 | MP0002184_abnormal_innervation | 1.16253115 |
| 66 | MP0000747_muscle_weakness | 1.15472351 |
| 67 | MP0000003_abnormal_adipose_tissue | 1.15399623 |
| 68 | MP0001440_abnormal_grooming_behavior | 1.14885982 |
| 69 | MP0002229_neurodegeneration | 1.13997445 |
| 70 | MP0004036_abnormal_muscle_relaxation | 1.13613074 |
| 71 | MP0009046_muscle_twitch | 1.12969053 |
| 72 | MP0004145_abnormal_muscle_electrophysio | 1.11553610 |
| 73 | MP0002067_abnormal_sensory_capabilities | 1.11352344 |
| 74 | MP0001529_abnormal_vocalization | 1.08318466 |
| 75 | MP0000751_myopathy | 1.08285200 |
| 76 | MP0006082_CNS_inflammation | 1.08192516 |
| 77 | MP0001986_abnormal_taste_sensitivity | 1.07081118 |
| 78 | MP0005220_abnormal_exocrine_pancreas | 1.06959305 |
| 79 | MP0005394_taste/olfaction_phenotype | 1.06354694 |
| 80 | MP0005499_abnormal_olfactory_system | 1.06354694 |
| 81 | MP0002876_abnormal_thyroid_physiology | 1.06217524 |
| 82 | MP0003075_altered_response_to | 1.05493756 |
| 83 | MP0008260_abnormal_autophagy | 1.05374360 |
| 84 | MP0004885_abnormal_endolymph | 1.04876567 |
| 85 | MP0001968_abnormal_touch/_nociception | 1.04821485 |
| 86 | MP0005310_abnormal_salivary_gland | 1.04818327 |
| 87 | MP0004924_abnormal_behavior | 1.04304896 |
| 88 | MP0005386_behavior/neurological_phenoty | 1.04304896 |
| 89 | MP0009840_abnormal_foam_cell | 1.04008424 |
| 90 | MP0002638_abnormal_pupillary_reflex | 1.03439762 |
| 91 | MP0005000_abnormal_immune_tolerance | 1.02727414 |
| 92 | MP0008877_abnormal_DNA_methylation | 1.02635063 |
| 93 | MP0003300_gastrointestinal_ulcer | 1.01780083 |
| 94 | MP0003011_delayed_dark_adaptation | 0.99745733 |
| 95 | MP0000955_abnormal_spinal_cord | 0.99253510 |
| 96 | MP0001800_abnormal_humoral_immune | 0.98074715 |
| 97 | MP0003221_abnormal_cardiomyocyte_apopto | 0.97338081 |
| 98 | MP0005365_abnormal_bile_salt | 0.96267513 |
| 99 | MP0000230_abnormal_systemic_arterial | 0.96139286 |
| 100 | MP0001666_abnormal_nutrient_absorption | 0.95336650 |
| 101 | MP0002090_abnormal_vision | 0.95182499 |
| 102 | MP0004142_abnormal_muscle_tone | 0.94444563 |
| 103 | MP0003959_abnormal_lean_body | 0.94059327 |
| 104 | MP0003303_peritoneal_inflammation | 0.93098991 |
| 105 | MP0003632_abnormal_nervous_system | 0.92765934 |
| 106 | MP0003868_abnormal_feces_composition | 0.92041141 |
| 107 | MP0004742_abnormal_vestibular_system | 0.91981543 |
| 108 | MP0003283_abnormal_digestive_organ | 0.91810223 |
| 109 | MP0003121_genomic_imprinting | 0.91496468 |
| 110 | MP0002882_abnormal_neuron_morphology | 0.90676732 |
| 111 | MP0003953_abnormal_hormone_level | 0.88851714 |
| 112 | MP0006072_abnormal_retinal_apoptosis | 0.88460286 |
| 113 | MP0002118_abnormal_lipid_homeostasis | 0.87815391 |
| 114 | MP0008995_early_reproductive_senescence | 0.87277167 |
| 115 | MP0002723_abnormal_immune_serum | 0.87071291 |
| 116 | MP0005083_abnormal_biliary_tract | 0.87004138 |
| 117 | MP0002066_abnormal_motor_capabilities/c | 0.86828168 |
| 118 | MP0003866_abnormal_defecation | 0.86644166 |
| 119 | MP0002420_abnormal_adaptive_immunity | 0.85223781 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.85156895 |
| 121 | MP0002139_abnormal_hepatobiliary_system | 0.84943645 |
| 122 | MP0003631_nervous_system_phenotype | 0.84199887 |
| 123 | MP0003122_maternal_imprinting | 0.83869545 |
| 124 | MP0001664_abnormal_digestion | 0.83529423 |
| 125 | MP0005025_abnormal_response_to | 0.83278261 |
| 126 | MP0001819_abnormal_immune_cell | 0.83243898 |
| 127 | MP0005551_abnormal_eye_electrophysiolog | 0.83127421 |
| 128 | MP0008874_decreased_physiological_sensi | 0.82733203 |
| 129 | MP0002419_abnormal_innate_immunity | 0.82577296 |
| 130 | MP0004085_abnormal_heartbeat | 0.82356854 |
| 131 | MP0001485_abnormal_pinna_reflex | 0.82231421 |
| 132 | MP0003879_abnormal_hair_cell | 0.82196968 |
| 133 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.81713546 |
| 134 | MP0002928_abnormal_bile_duct | 0.81098245 |
| 135 | MP0009785_altered_susceptibility_to | 0.80522544 |
| 136 | MP0002069_abnormal_eating/drinking_beha | 0.79491618 |
| 137 | MP0005253_abnormal_eye_physiology | 0.79272440 |
| 138 | MP0005448_abnormal_energy_balance | 0.78686266 |
| 139 | MP0001177_atelectasis | 0.74400631 |
| 140 | MP0005387_immune_system_phenotype | 0.73050484 |
| 141 | MP0001790_abnormal_immune_system | 0.73050484 |
| 142 | MP0001835_abnormal_antigen_presentation | 0.71186099 |
| 143 | MP0002452_abnormal_antigen_presenting | 0.71074503 |
| 144 | MP0001963_abnormal_hearing_physiology | 0.70766537 |
| 145 | MP0002009_preneoplasia | 0.70209596 |
| 146 | MP0002332_abnormal_exercise_endurance | 0.69931315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Polyphagia (HP:0002591) | 4.22283876 |
| 2 | Neurofibrillary tangles (HP:0002185) | 4.02192747 |
| 3 | Amyotrophic lateral sclerosis (HP:0007354) | 3.83106251 |
| 4 | Visual hallucinations (HP:0002367) | 3.61677394 |
| 5 | Hypothermia (HP:0002045) | 3.60695057 |
| 6 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.58563462 |
| 7 | Pheochromocytoma (HP:0002666) | 3.50327491 |
| 8 | Retinal dysplasia (HP:0007973) | 3.37136763 |
| 9 | Supranuclear gaze palsy (HP:0000605) | 3.33558227 |
| 10 | Neuroendocrine neoplasm (HP:0100634) | 3.29686804 |
| 11 | Cerebral inclusion bodies (HP:0100314) | 3.25939133 |
| 12 | Febrile seizures (HP:0002373) | 3.25245927 |
| 13 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.23946486 |
| 14 | Ketoacidosis (HP:0001993) | 3.23565967 |
| 15 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.18937845 |
| 16 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.18937845 |
| 17 | Dysostosis multiplex (HP:0000943) | 3.17894704 |
| 18 | Gait imbalance (HP:0002141) | 3.09050967 |
| 19 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.08272439 |
| 20 | Stomatitis (HP:0010280) | 3.04926804 |
| 21 | Agitation (HP:0000713) | 3.04277040 |
| 22 | Hypoglycemic seizures (HP:0002173) | 3.00637900 |
| 23 | Mutism (HP:0002300) | 2.97006929 |
| 24 | Abnormality of binocular vision (HP:0011514) | 2.95502929 |
| 25 | Diplopia (HP:0000651) | 2.95502929 |
| 26 | Peripheral hypomyelination (HP:0007182) | 2.91111647 |
| 27 | Abnormal ciliary motility (HP:0012262) | 2.90887913 |
| 28 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.88297010 |
| 29 | Progressive cerebellar ataxia (HP:0002073) | 2.83092728 |
| 30 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.74139736 |
| 31 | Absent/shortened dynein arms (HP:0200106) | 2.74139736 |
| 32 | Atonic seizures (HP:0010819) | 2.68955292 |
| 33 | Congenital primary aphakia (HP:0007707) | 2.68432653 |
| 34 | Hypoglycemic coma (HP:0001325) | 2.67121204 |
| 35 | Urinary urgency (HP:0000012) | 2.65714347 |
| 36 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.63898977 |
| 37 | Type II lissencephaly (HP:0007260) | 2.61857417 |
| 38 | Abnormality of the corticospinal tract (HP:0002492) | 2.60643378 |
| 39 | Nephrogenic diabetes insipidus (HP:0009806) | 2.59781942 |
| 40 | Medial flaring of the eyebrow (HP:0010747) | 2.58395594 |
| 41 | Hemiplegia (HP:0002301) | 2.57609926 |
| 42 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.56025598 |
| 43 | Mucopolysacchariduria (HP:0008155) | 2.56025598 |
| 44 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.53474962 |
| 45 | Progressive neurologic deterioration (HP:0002344) | 2.51809463 |
| 46 | Eczematoid dermatitis (HP:0000976) | 2.48522208 |
| 47 | Limb dystonia (HP:0002451) | 2.47765661 |
| 48 | Split foot (HP:0001839) | 2.43637094 |
| 49 | Focal motor seizures (HP:0011153) | 2.42536946 |
| 50 | Anxiety (HP:0000739) | 2.42202385 |
| 51 | Ketosis (HP:0001946) | 2.41734682 |
| 52 | Symptomatic seizures (HP:0011145) | 2.40378112 |
| 53 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.39959481 |
| 54 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.38449827 |
| 55 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.38449827 |
| 56 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.38449827 |
| 57 | Ankle clonus (HP:0011448) | 2.34230728 |
| 58 | Absent speech (HP:0001344) | 2.32981386 |
| 59 | Cerebral hemorrhage (HP:0001342) | 2.31683866 |
| 60 | Myokymia (HP:0002411) | 2.30327636 |
| 61 | Hemiparesis (HP:0001269) | 2.28804334 |
| 62 | T lymphocytopenia (HP:0005403) | 2.25506044 |
| 63 | Excessive salivation (HP:0003781) | 2.24959724 |
| 64 | Retinal atrophy (HP:0001105) | 2.24829988 |
| 65 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.21218438 |
| 66 | Absence seizures (HP:0002121) | 2.20255430 |
| 67 | Specific learning disability (HP:0001328) | 2.18739285 |
| 68 | Ulnar claw (HP:0001178) | 2.18080703 |
| 69 | Depression (HP:0000716) | 2.17567294 |
| 70 | Progressive inability to walk (HP:0002505) | 2.17114405 |
| 71 | Large for gestational age (HP:0001520) | 2.16076520 |
| 72 | Palpitations (HP:0001962) | 2.16033590 |
| 73 | Late onset (HP:0003584) | 2.15167946 |
| 74 | Exercise-induced myalgia (HP:0003738) | 2.15038054 |
| 75 | Drooling (HP:0002307) | 2.14291840 |
| 76 | Severe combined immunodeficiency (HP:0004430) | 2.12818627 |
| 77 | Increased cerebral lipofuscin (HP:0011813) | 2.11690719 |
| 78 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.11683376 |
| 79 | Delusions (HP:0000746) | 2.11210731 |
| 80 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.11073206 |
| 81 | Recurrent sinusitis (HP:0011108) | 2.11027267 |
| 82 | Vacuolated lymphocytes (HP:0001922) | 2.07831174 |
| 83 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.06666405 |
| 84 | Decreased circulating renin level (HP:0003351) | 2.06665449 |
| 85 | Abnormality of T cell number (HP:0011839) | 2.05966977 |
| 86 | Increased circulating renin level (HP:0000848) | 2.03232951 |
| 87 | Abnormal pupillary function (HP:0007686) | 2.03157273 |
| 88 | Bronchiectasis (HP:0002110) | 2.03121321 |
| 89 | Postural instability (HP:0002172) | 2.00531204 |
| 90 | Spastic tetraplegia (HP:0002510) | 2.00267548 |
| 91 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.99970866 |
| 92 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.99970866 |
| 93 | Abnormality of glycolipid metabolism (HP:0010969) | 1.99970866 |
| 94 | Megalencephaly (HP:0001355) | 1.98964314 |
| 95 | Dysdiadochokinesis (HP:0002075) | 1.97423243 |
| 96 | Poor suck (HP:0002033) | 1.97414134 |
| 97 | Psychosis (HP:0000709) | 1.97381580 |
| 98 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.94372818 |
| 99 | Focal seizures (HP:0007359) | 1.93889284 |
| 100 | Generalized tonic-clonic seizures (HP:0002069) | 1.93083729 |
| 101 | Sleep apnea (HP:0010535) | 1.92066723 |
| 102 | Hyperparathyroidism (HP:0000843) | 1.91803785 |
| 103 | Dialeptic seizures (HP:0011146) | 1.91094502 |
| 104 | Abnormality of the lower motor neuron (HP:0002366) | 1.90153379 |
| 105 | Restlessness (HP:0000711) | 1.89007464 |
| 106 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.88342869 |
| 107 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.88342869 |
| 108 | Papilledema (HP:0001085) | 1.88056372 |
| 109 | Myoglobinuria (HP:0002913) | 1.87776847 |
| 110 | Spastic gait (HP:0002064) | 1.85885957 |
| 111 | Abnormality of eosinophils (HP:0001879) | 1.85219368 |
| 112 | Hypercortisolism (HP:0001578) | 1.85219103 |
| 113 | Myositis (HP:0100614) | 1.84480024 |
| 114 | Sensorimotor neuropathy (HP:0007141) | 1.84361105 |
| 115 | Scanning speech (HP:0002168) | 1.83682827 |
| 116 | Rapidly progressive (HP:0003678) | 1.83676729 |
| 117 | Torticollis (HP:0000473) | 1.82870018 |
| 118 | Genital tract atresia (HP:0001827) | 1.82668094 |
| 119 | Genetic anticipation (HP:0003743) | 1.82545829 |
| 120 | Asymmetric septal hypertrophy (HP:0001670) | 1.82008698 |
| 121 | Dyskinesia (HP:0100660) | 1.81684431 |
| 122 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.81498360 |
| 123 | Menstrual irregularities (HP:0000858) | 1.80694171 |
| 124 | Anosmia (HP:0000458) | 1.80475033 |
| 125 | EEG with generalized epileptiform discharges (HP:0011198) | 1.78839416 |
| 126 | Growth hormone excess (HP:0000845) | 1.78492431 |
| 127 | Truncal ataxia (HP:0002078) | 1.77825359 |
| 128 | Clonus (HP:0002169) | 1.77188770 |
| 129 | Retrobulbar optic neuritis (HP:0100654) | 1.76487387 |
| 130 | Optic neuritis (HP:0100653) | 1.76487387 |
| 131 | Oligomenorrhea (HP:0000876) | 1.76427807 |
| 132 | Vaginal atresia (HP:0000148) | 1.76204030 |
| 133 | Dysmetria (HP:0001310) | 1.74816018 |
| 134 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.73620826 |
| 135 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.73620826 |
| 136 | Stomach cancer (HP:0012126) | 1.73468813 |
| 137 | Rigidity (HP:0002063) | 1.73151049 |
| 138 | Intention tremor (HP:0002080) | 1.73150913 |
| 139 | Epileptiform EEG discharges (HP:0011182) | 1.72266351 |
| 140 | Prolonged QT interval (HP:0001657) | 1.72193700 |
| 141 | Diminished motivation (HP:0000745) | 1.72105934 |
| 142 | Abnormal neuron morphology (HP:0012757) | 1.71135663 |
| 143 | Abnormality of the motor neurons (HP:0002450) | 1.71135663 |
| 144 | Hypsarrhythmia (HP:0002521) | 1.71102551 |
| 145 | Apathy (HP:0000741) | 1.71083619 |
| 146 | Syncope (HP:0001279) | 1.70994042 |
| 147 | Hypokalemia (HP:0002900) | 1.69126175 |
| 148 | Abnormality of the nasal mucosa (HP:0000433) | 1.68892324 |
| 149 | Abnormal eating behavior (HP:0100738) | 1.68628835 |
| 150 | Hyperphosphatemia (HP:0002905) | 1.67917091 |
| 151 | Tachypnea (HP:0002789) | 1.67877570 |
| 152 | Abnormality of macular pigmentation (HP:0008002) | 1.67862555 |
| 153 | Abnormality of renin-angiotensin system (HP:0000847) | 1.67141659 |
| 154 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.65024894 |
| 155 | Hyperventilation (HP:0002883) | 1.64190852 |
| 156 | Rhinitis (HP:0012384) | 1.63484374 |
| 157 | Action tremor (HP:0002345) | 1.63305242 |
| 158 | Nasal polyposis (HP:0100582) | 1.63252497 |
| 159 | Abnormality of the intrinsic pathway (HP:0010989) | 1.60739029 |
| 160 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.60545071 |
| 161 | Hypokalemic alkalosis (HP:0001949) | 1.59309848 |
| 162 | Epileptic encephalopathy (HP:0200134) | 1.58602919 |
| 163 | Failure to thrive in infancy (HP:0001531) | 1.58494583 |
| 164 | Lower limb muscle weakness (HP:0007340) | 1.58244128 |
| 165 | Neuronal loss in central nervous system (HP:0002529) | 1.58179649 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCR | 2.80803326 |
| 2 | PHKG1 | 2.58569960 |
| 3 | PHKG2 | 2.58569960 |
| 4 | MAPK15 | 2.47535206 |
| 5 | CAMKK2 | 2.21735707 |
| 6 | SIK3 | 2.17991568 |
| 7 | INSRR | 2.09221840 |
| 8 | NTRK1 | 2.03044289 |
| 9 | CASK | 2.01367499 |
| 10 | NTRK3 | 1.99662152 |
| 11 | BCKDK | 1.95087855 |
| 12 | MAP3K2 | 1.89226517 |
| 13 | ARAF | 1.88983753 |
| 14 | SIK2 | 1.78975825 |
| 15 | ERBB3 | 1.73197956 |
| 16 | TAOK3 | 1.65602449 |
| 17 | MAP4K2 | 1.63318528 |
| 18 | WNK4 | 1.62782627 |
| 19 | PAK3 | 1.62768575 |
| 20 | MAPKAPK5 | 1.58886664 |
| 21 | TRIM28 | 1.54890147 |
| 22 | ERN1 | 1.50877718 |
| 23 | TNIK | 1.47578180 |
| 24 | PRKD3 | 1.47037172 |
| 25 | STK39 | 1.46647777 |
| 26 | MAP3K9 | 1.41892005 |
| 27 | PRKCH | 1.38848913 |
| 28 | EPHB1 | 1.38497787 |
| 29 | TRIB3 | 1.36403242 |
| 30 | HIPK2 | 1.35572180 |
| 31 | NTRK2 | 1.31881363 |
| 32 | TXK | 1.31704961 |
| 33 | MAP3K13 | 1.31023092 |
| 34 | LMTK2 | 1.28564313 |
| 35 | KSR2 | 1.24750109 |
| 36 | MAP3K12 | 1.24455309 |
| 37 | GRK6 | 1.23624559 |
| 38 | DYRK1B | 1.21117844 |
| 39 | RIPK4 | 1.18116553 |
| 40 | FGFR4 | 1.17952617 |
| 41 | FLT3 | 1.17291175 |
| 42 | ITK | 1.16965490 |
| 43 | MAP3K1 | 1.14347568 |
| 44 | OXSR1 | 1.11440092 |
| 45 | CAMKK1 | 1.09470599 |
| 46 | CAMK2D | 1.09146866 |
| 47 | UHMK1 | 1.07915150 |
| 48 | IRAK1 | 1.07392259 |
| 49 | MAP3K11 | 1.06886539 |
| 50 | CDK19 | 1.06122804 |
| 51 | CSNK1G2 | 1.05443515 |
| 52 | TESK1 | 1.05285206 |
| 53 | CAMK2B | 1.05236765 |
| 54 | DYRK1A | 1.04800076 |
| 55 | MAP3K4 | 1.03037872 |
| 56 | MINK1 | 1.02287169 |
| 57 | RET | 1.01527942 |
| 58 | MUSK | 1.00965538 |
| 59 | ZAP70 | 0.94875444 |
| 60 | CSNK1G3 | 0.94570362 |
| 61 | CDK5 | 0.93331487 |
| 62 | EPHA3 | 0.92325082 |
| 63 | IRAK2 | 0.92319077 |
| 64 | SIK1 | 0.90377555 |
| 65 | MAP2K7 | 0.90345293 |
| 66 | TESK2 | 0.90067933 |
| 67 | CAMK2G | 0.89450911 |
| 68 | DYRK2 | 0.89350152 |
| 69 | EPHA4 | 0.88039650 |
| 70 | PAK6 | 0.87526005 |
| 71 | SYK | 0.85385048 |
| 72 | CAMK2A | 0.85153301 |
| 73 | MAP2K4 | 0.83952603 |
| 74 | SCYL2 | 0.83465498 |
| 75 | NLK | 0.82538597 |
| 76 | MARK1 | 0.80224712 |
| 77 | LCK | 0.78680798 |
| 78 | MAP3K5 | 0.78039586 |
| 79 | PASK | 0.74862598 |
| 80 | HCK | 0.74621219 |
| 81 | GRK5 | 0.74368017 |
| 82 | MARK2 | 0.74288683 |
| 83 | CSK | 0.72901911 |
| 84 | MAP3K6 | 0.72531285 |
| 85 | MAPKAPK3 | 0.71701093 |
| 86 | TGFBR2 | 0.71235736 |
| 87 | PINK1 | 0.69920216 |
| 88 | CSNK1G1 | 0.69536758 |
| 89 | JAK1 | 0.68437130 |
| 90 | GRK7 | 0.68419660 |
| 91 | JAK3 | 0.67375334 |
| 92 | PRKD2 | 0.66712896 |
| 93 | MAP4K1 | 0.66677060 |
| 94 | PRKCG | 0.66266448 |
| 95 | CDK14 | 0.64983254 |
| 96 | MAPK13 | 0.64653835 |
| 97 | PDK1 | 0.64350327 |
| 98 | FES | 0.64205660 |
| 99 | IKBKE | 0.63926453 |
| 100 | CAMK4 | 0.63629507 |
| 101 | PDPK1 | 0.62968703 |
| 102 | DAPK2 | 0.62444603 |
| 103 | CSNK1A1L | 0.62184030 |
| 104 | LYN | 0.61594713 |
| 105 | TBK1 | 0.61533603 |
| 106 | CAMK1G | 0.60592125 |
| 107 | SGK2 | 0.59382665 |
| 108 | RPS6KA4 | 0.59169604 |
| 109 | MOS | 0.59010342 |
| 110 | JAK2 | 0.58128392 |
| 111 | SGK494 | 0.57597383 |
| 112 | SGK223 | 0.57597383 |
| 113 | PRKCE | 0.57242479 |
| 114 | ADRBK2 | 0.56050038 |
| 115 | NEK6 | 0.55698718 |
| 116 | MYLK | 0.55519052 |
| 117 | KSR1 | 0.55212851 |
| 118 | BMPR2 | 0.55006335 |
| 119 | TYK2 | 0.53735018 |
| 120 | BTK | 0.53734111 |
| 121 | CAMK1 | 0.52351056 |
| 122 | STK38 | 0.50016458 |
| 123 | PLK2 | 0.49496304 |
| 124 | LIMK1 | 0.49407098 |
| 125 | PRKCQ | 0.48980147 |
| 126 | PRKD1 | 0.48913246 |
| 127 | TYRO3 | 0.48390897 |
| 128 | PKN2 | 0.47989592 |
| 129 | MAP3K7 | 0.47789488 |
| 130 | PRPF4B | 0.47441119 |
| 131 | MAPK7 | 0.46178979 |
| 132 | MAPK12 | 0.46025324 |
| 133 | TNK2 | 0.45983368 |
| 134 | WNK3 | 0.45621930 |
| 135 | STK11 | 0.42299575 |
| 136 | PRKCZ | 0.41903292 |
| 137 | FYN | 0.41754665 |
| 138 | MAP3K14 | 0.41660518 |
| 139 | CDK18 | 0.39646848 |
| 140 | EGFR | 0.38548489 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 2.67108754 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.60958918 |
| 3 | Protein export_Homo sapiens_hsa03060 | 2.39548503 |
| 4 | Insulin secretion_Homo sapiens_hsa04911 | 2.24194827 |
| 5 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.96944402 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.87595945 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.83788259 |
| 8 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.76264417 |
| 9 | Cocaine addiction_Homo sapiens_hsa05030 | 1.74499134 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 1.72805806 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.49723284 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.49412838 |
| 13 | Circadian entrainment_Homo sapiens_hsa04713 | 1.47960243 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.46296946 |
| 15 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.43721701 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 1.42024694 |
| 17 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.40527369 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.38195911 |
| 19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.36497703 |
| 20 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.35387197 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.29625832 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.26558923 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.25069694 |
| 24 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.24926424 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.22748044 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.22088912 |
| 27 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.19119869 |
| 28 | Salivary secretion_Homo sapiens_hsa04970 | 1.19054562 |
| 29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.18327525 |
| 30 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.17708553 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.16805719 |
| 32 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.15738212 |
| 33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.13693868 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.12616710 |
| 35 | Nicotine addiction_Homo sapiens_hsa05033 | 1.12243643 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 1.11998345 |
| 37 | Long-term potentiation_Homo sapiens_hsa04720 | 1.11425034 |
| 38 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.10255487 |
| 39 | Renin secretion_Homo sapiens_hsa04924 | 1.08911441 |
| 40 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.07628806 |
| 41 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.07584117 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 1.02512550 |
| 43 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.01786377 |
| 44 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.00566802 |
| 45 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.00556493 |
| 46 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.00266651 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.96793088 |
| 48 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.96327366 |
| 49 | Other glycan degradation_Homo sapiens_hsa00511 | 0.96096163 |
| 50 | Alzheimers disease_Homo sapiens_hsa05010 | 0.95707759 |
| 51 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.95221074 |
| 52 | Parkinsons disease_Homo sapiens_hsa05012 | 0.95032118 |
| 53 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.94167898 |
| 54 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.93451318 |
| 55 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.92284465 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89484978 |
| 57 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.89011302 |
| 58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.86641096 |
| 59 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.84002334 |
| 60 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.82528309 |
| 61 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.81135331 |
| 62 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.81042546 |
| 63 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.80733971 |
| 64 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.80420832 |
| 65 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.80211040 |
| 66 | Prion diseases_Homo sapiens_hsa05020 | 0.80107435 |
| 67 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.80103134 |
| 68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.79638033 |
| 69 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.79544966 |
| 70 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.79248399 |
| 71 | Allograft rejection_Homo sapiens_hsa05330 | 0.76967722 |
| 72 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.75934088 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.74515165 |
| 74 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.74447912 |
| 75 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.73916193 |
| 76 | Salmonella infection_Homo sapiens_hsa05132 | 0.70767305 |
| 77 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69458232 |
| 78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68610687 |
| 79 | Tuberculosis_Homo sapiens_hsa05152 | 0.68250558 |
| 80 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.68122552 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67854554 |
| 82 | Histidine metabolism_Homo sapiens_hsa00340 | 0.66902990 |
| 83 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.66725200 |
| 84 | Bile secretion_Homo sapiens_hsa04976 | 0.66127188 |
| 85 | ABC transporters_Homo sapiens_hsa02010 | 0.65432155 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.65066571 |
| 87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65041655 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.64910096 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64492799 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61462316 |
| 91 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.61144021 |
| 92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.60457539 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59866299 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59251555 |
| 95 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.58829970 |
| 96 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.57615082 |
| 97 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.57519203 |
| 98 | Shigellosis_Homo sapiens_hsa05131 | 0.57486816 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.57349446 |
| 100 | Pertussis_Homo sapiens_hsa05133 | 0.57242865 |
| 101 | Legionellosis_Homo sapiens_hsa05134 | 0.56868558 |
| 102 | Axon guidance_Homo sapiens_hsa04360 | 0.56737167 |
| 103 | Long-term depression_Homo sapiens_hsa04730 | 0.56727619 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.55824532 |
| 105 | Viral myocarditis_Homo sapiens_hsa05416 | 0.55001589 |
| 106 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.54488036 |
| 107 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.53632338 |
| 108 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.52494706 |
| 109 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.52378960 |
| 110 | Gap junction_Homo sapiens_hsa04540 | 0.52355479 |
| 111 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.52044490 |
| 112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51693535 |
| 113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51350175 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49575144 |
| 115 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.48951405 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47917699 |
| 117 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.47439916 |
| 118 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.47436618 |
| 119 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46824812 |
| 120 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.46755897 |
| 121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45294215 |
| 122 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.45118490 |
| 123 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.43982165 |
| 124 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.43183524 |
| 125 | Peroxisome_Homo sapiens_hsa04146 | 0.43086896 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.41873516 |
| 127 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41616367 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41608039 |
| 129 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41480757 |
| 130 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41406018 |
| 131 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.41238550 |
| 132 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40504033 |
| 133 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.40472624 |
| 134 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.38266687 |
| 135 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.37889808 |
| 136 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.37501924 |
| 137 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.37448763 |
| 138 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.36674171 |
| 139 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36456545 |
| 140 | Leishmaniasis_Homo sapiens_hsa05140 | 0.36119319 |

